As of 2026-02-25, the Relative Valuation of STAAR Surgical Co (STAA) is (44.66) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.75 USD, the upside of STAAR Surgical Co based on Relative Valuation is -326.1%.
The range of the Relative Valuation is (43.94) - (47.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.7x - 32.8x | 29.1x |
| Forward P/E multiples | 16.8x - 24.3x | 17.0x |
| Fair Price | (43.94) - (47.12) | (44.66) |
| Upside | -322.5% - -338.6% | -326.1% |
| Date | P/E |
| 2026-02-24 | -10.19 |
| 2026-02-23 | -9.39 |
| 2026-02-20 | -9.17 |
| 2026-02-19 | -9.23 |
| 2026-02-18 | -9.06 |
| 2026-02-17 | -8.36 |
| 2026-02-13 | -8.31 |
| 2026-02-12 | -8.51 |
| 2026-02-11 | -8.90 |
| 2026-02-10 | -8.93 |
| 2026-02-09 | -8.99 |
| 2026-02-06 | -9.07 |
| 2026-02-05 | -8.81 |
| 2026-02-04 | -9.05 |
| 2026-02-03 | -9.37 |
| 2026-02-02 | -9.31 |
| 2026-01-30 | -9.78 |
| 2026-01-29 | -9.78 |
| 2026-01-28 | -9.88 |
| 2026-01-27 | -9.83 |
| 2026-01-26 | -9.86 |
| 2026-01-23 | -9.88 |
| 2026-01-22 | -10.27 |
| 2026-01-21 | -10.64 |
| 2026-01-20 | -10.82 |
| 2026-01-16 | -10.82 |
| 2026-01-15 | -10.82 |
| 2026-01-14 | -11.26 |
| 2026-01-13 | -10.91 |
| 2026-01-12 | -11.36 |
| 2026-01-09 | -11.42 |
| 2026-01-08 | -11.61 |
| 2026-01-07 | -11.45 |
| 2026-01-06 | -11.50 |
| 2026-01-05 | -12.36 |
| 2026-01-02 | -12.18 |
| 2025-12-31 | -11.92 |
| 2025-12-30 | -11.98 |
| 2025-12-29 | -12.07 |
| 2025-12-26 | -12.05 |
| 2025-12-24 | -12.20 |
| 2025-12-23 | -12.35 |
| 2025-12-22 | -12.49 |
| 2025-12-19 | -12.98 |
| 2025-12-18 | -12.40 |
| 2025-12-17 | -13.36 |
| 2025-12-16 | -12.80 |
| 2025-12-15 | -12.16 |
| 2025-12-12 | -12.45 |
| 2025-12-11 | -12.74 |